期刊文献+

脑康Ⅱ号干预糖尿病认知障碍大鼠血清3-脱氧葡糖醛酮的研究 被引量:4

Intervention of Serum 3-deoxyglucosone by Naokang Ⅱ in Rats with Diabetes Mellitus and Cognitive Impairment
原文传递
导出
摘要 目的:研究脑康Ⅱ号对糖尿病大鼠学习记忆功能的干预情况。方法:将3月龄雄性Wistar大鼠分为对照组、模型组、脑康Ⅱ号干预组(分为高、中、低剂量3组),模型组和脑康Ⅱ号干预组用链脲佐菌素60 mg·kg-1剂量ip,对照组ip相同体积的枸橼酸缓冲液,脑康Ⅱ号干预组分别使用20,10,5 g·kg-1的脑康Ⅱ号ig,采用水迷宫实验和气相色谱-质谱联用仪,分别观察糖尿病大鼠的行为学改变和血清3-脱氧葡糖醛酮(3-DG)的变化。结果:造模后模型组和中药干预组大鼠血糖较对照组显著升高(P<0.01)。Morris水迷宫检测大鼠到达站台时间显示,模型组需(18.6±6.3)s时间较对照组(7.5±3.1)s明显延长,具有显著性差异(P<0.01)。脑康Ⅱ号各治疗组所需时间(低、中、高剂量组分别为(9.9±3.2)s,(8.7±4.1)s,(10.1±3.9)s,较模型组明显减少(P<0.01)。糖尿病大鼠模型血清中3-DG含量(20.19±2.62)ng.mL-1,较对照组显著升高(P<0.05),约为对照组(7.02±1.19)ng.mL-1的2.5倍。脑康Ⅱ号高剂量治疗组3-DG含量较模型组显著降低(8.89±1.09)ng.mL-1(P<0.05)。结论:脑康Ⅱ号能够通过降低大鼠血清3-脱氧葡糖醛酮的水平,改善糖尿病大鼠认知障碍。 Objective:To study the influence of Naokang Ⅱ on diabetes mellitus and cognitive impairment in rats.Method:We used Naokang Ⅱ to treat rats with diabetes mellitus and cognitive impairment.We observed the change of rat's ability of learning and memory function,by the application of water maze,and examined the blood serum 3-deoxyglucosone using gas chromatography-mass spectrometry.Result:Naokang Ⅱcould not reduce rats serum glucose,but it could significantly reduce the swimming time to platform and serum 3-deoxyglucosone.Conclusion:Naokang Ⅱ could improve diabetes mellitus rat's cognitive impairment,by reducing serum 3-deoxyglucosone.
出处 《中国实验方剂学杂志》 CAS 北大核心 2011年第10期119-121,共3页 Chinese Journal of Experimental Traditional Medical Formulae
基金 国家自然科学基金项目(81041022) 北京市自然科学基金项目(7102073) 北京市科技新星项目(2008A090)
关键词 脑康Ⅱ号 糖尿病 认知障碍 3-脱氧葡糖醛酮 Naokang Ⅱ diabetes mellitus cognitive impairment 3-deoxyglucosone
  • 相关文献

参考文献8

  • 1Debling D,Amelang M,Hasselbach P,et al.Diabetes and cognitive function in a population-based study of elderly women and men[J].J Diabetes Complications,2006,20 (4):238.
  • 2Fischer P,Jungwirth S,Zehetmayer S,et al.Conversion from subtypes of mild cognitive impairment to Alzheimer dementia[J].Neurology,2007,68(4):288.
  • 3Odani H,Shinzato T,Matsumoto Y,et al.Increase in three alpha,beta-dicarbonyl compound levels in human uremic plasma:specific in vivo determination of intermediates in advanced Maillard reaction[J].Biochem Biophys Res Commun,1999,256(1):89.
  • 4Sima A A,Kamiya H,Li Z G.Insulin,C-peptide,hyperglycemia,and central nervous system complications in diabetes[J].Eur J Pharmacol,2004,490(1/ 3):187.
  • 5Sato T,Shimogaito N,Wu X,et al.Toxic advanced glycation end products (TAGE) theory in Alzheimer 's disease[J].Am J Alzheimers Dis Other Demen,2006,21(3):197.
  • 6黄小波,李宗信,陈文强,王宁群.2型糖尿病认知障碍患者的中医证候聚类分析[J].中国中西医结合急救杂志,2009,16(1):11-13. 被引量:20
  • 7Thornalley P J,Anngborg A,Minhas H S.Formation of glyoxal,methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose[J].Biochem J,1999,344(1):109.
  • 8Beisswenger P J,Drummond K S,Nelson R G,et al.Susceptibility to diabetic nephropathy is related to dicarbonyl and oxidative stress[J].Diabetes,2005,54 (11):3274.

二级参考文献8

  • 1梁晓春.中医中药治疗糖尿病高脂血症研究进展[J].中国中西医结合急救杂志,2007,14(4):254-256. 被引量:11
  • 2Debling D,Amelang M,Hasselbach P,et al.Diabetes and cognitive function in a population-based study of elderly women and men[J].J Diabetes Complications,2006,20(4):238-245.
  • 3Fischer P,Jungwirth S,Zehetmayer S,et al.Conversion from subtypes of mild cognitive impairment to Alzheimer dementia[J].Neurology,2007,68(4):288-291.
  • 4Petersen RC,Smith GE,Waring SC,et al.Mild cognitive impairment:clinical characterization and outcome[J].Arch Neurol,1999,56(3):303-308.
  • 5国家中医药管理局.ZY/T 001.1-001.994中医病证诊断疗效标准[S].南京:南京大学出版社,1995:19-25.
  • 6国家技术监督局.GB/T 16751.21997中华人民共和国国家标准·中医临床诊疗术语--证候部分[S].北京:中国标准出版社,1997:1-12.
  • 7Sima AA,Kamiya H,Li ZG.Insulin,C-peptide,hyperglycemia,and central nervous system complications in diabetes[J].Eur J Pharmacol,2004,490(1-3):187-197.
  • 8Li ZG,Zhang W,Sima AA.The role of impaired insulin/IGF action in primary diabetic encephalopathy[J].Brain Res,2005,1037(1-2):12-24.

共引文献19

同被引文献55

  • 1宋福印,吕明芮,陈孝银,刘广明.愈消通脉散对糖尿病大鼠脑组织超微结构及其相关因素的影响[J].中国中医基础医学杂志,2005,11(9):673-674. 被引量:2
  • 2中国防治认知功能障碍专家共识专家组.中国防治认知功能障碍专家共识[J].中华内科杂志,2006,45(2):171-173. 被引量:557
  • 3田国庆.糖尿病脑病与消渴病兼证“呆症”及其中医治疗[J].中国临床医生杂志,2006,34(5):12-13. 被引量:13
  • 4潘善余.益肾化痰祛瘀法治疗糖尿病脑病证治探讨[J].浙江中医杂志,2006,41(10):594-594. 被引量:4
  • 5Mijnhout Gs,Seheltens P.Diamant M,et al.Diabeticencep halopathy:a concept in need of a definition[J].Diabetologia,2006,49:1447-1448.
  • 6袁国桢,季向东,王群松,等.补肾祛瘀益智汤治疗糖尿病认知功能障碍临床研究[C].第十二届全国中西医结合精神疾病学术会议论文集,2013:23-26.
  • 7王春花.2型糖尿病轻度认知功能障碍脾虚型及TOMM40基因等相关因素的研究[D].福建中医药大学:陈刚,2009.
  • 8Sima A A,Kamiya H,Li Z G.Insulin,C-peptide,hyperglycemia,and central nervous system complications in diabetes[J].Eur J Pharmacol,2004,490(1/3):187-197.
  • 9Van Dyke K,Jabbour N,Hoeldtke R,et al.Oxidative-nitrosative stresses trigger typeⅠdiabetes:preventable in streptozotocin rats and detectable in human disease[J].Ann N Y Acad Sci,2010,1203:138-145.
  • 10Kuhad A,Chopra K.Tocotrienol attenuates oxidative-nitrosative stress and inflammatory cascade in experimental model of diabetic neuropathy[J].Neuropharmacology,2009,57(4):456-462.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部